Clinical Trial Confidentiality Agreement Template for Singapore

A Clinical Trial Confidentiality Agreement is a legally binding contract that protects sensitive information shared during medical research activities in Singapore. You need this document to establish clear confidentiality obligations before disclosing proprietary research data, trial protocols, patient information, or other confidential materials to research partners, investigators, or third parties involved in clinical trials.

When do you need this document?

You require this agreement when pharmaceutical companies engage research institutions or contract research organizations for clinical trials in Singapore. It's essential before sharing study protocols with principal investigators, when collaborating with multiple research sites, or when involving third-party service providers who will access confidential trial data. The agreement is also necessary when international sponsors work with local Singapore research institutions, ensuring compliance with both local regulations and global research standards. You need it before any confidential information exchange occurs, including preliminary discussions about potential research collaborations.

Key legal considerations

Your agreement must clearly define what constitutes confidential information, including trial protocols, patient data, research methodologies, regulatory submissions, and commercial information. You should specify the permitted uses of confidential information, ensuring they align with the clinical trial's legitimate purposes while preventing unauthorized disclosure or commercial exploitation. The agreement must include robust data security obligations, requiring appropriate technical and organizational measures to protect personal data and confidential information. You need provisions addressing the return or destruction of confidential materials upon completion or termination of the trial. Consider including specific clauses for handling adverse events, regulatory reporting requirements, and publication rights, as these often involve sharing confidential information with regulatory authorities or in scientific publications.

Legal requirements in Singapore

Your Clinical Trial Confidentiality Agreement must comply with Singapore's Personal Data Protection Act 2012, which governs the collection, use, and disclosure of personal data, including patient information in clinical trials. The agreement should align with the Human Biomedical Research Act 2015, which regulates human biomedical research and mandates protection of research subjects' rights and welfare. You must ensure compliance with the Healthcare Services Act 2020 and relevant provisions of the Medicines Act, particularly the Medicines (Clinical Trials) Regulations that govern clinical trial conduct. The agreement should address cross-border data transfer requirements under the PDPA, especially when working with international sponsors or contract research organizations. You need to include provisions for regulatory disclosure obligations, as Singapore law requires reporting of certain information to the Health Sciences Authority and institutional review boards, which may necessitate disclosure of otherwise confidential information for regulatory compliance purposes.